JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1987; 9:1024-1030
© 1987 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mercadier, J.
Right arrow Articles by Schwartz, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mercadier, J.
Right arrow Articles by Schwartz, K

Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: a quantitative study

JJ Mercadier, D de la Bastie, P Menasche, A N'Guyen Van Cao, P Bouveret, P Lorente, A Piwnica, R Slama, and K Schwartz

The cardiac myosin phenotype, an important determinant of myocardial contractility, is modified by chronic increases in hemodynamic load. To quantify the proportion of atrial alpha-myosin heavy chain in various types of left atrial overload and to assess the possible relation between this proportion and atrial size, 34 patients were studied, 4 with Wolff-Parkinson-White syndrome, 29 with various types of mitral valve dysfunction and 1 with an atrial septal defect. Four normal autopsy hearts were also studied. The proportion of alpha-myosin heavy chain among total (alpha plus beta) myosin heavy chains was determined in each atrial sample, using an enzyme-linked immunosorbent assay. The size of the left atrium was assessed by one- and two-dimensional echocardiography. Alpha-myosin heavy chain was the main isoform present in the normal atria (85.5 +/- 9% of total myosin heavy chains). Patients with pure tight mitral stenosis (n = 9), mitral stenosis plus mild regurgitation (n = 8) and severe mitral regurgitation (n = 8), who had a higher indexed left atrial transverse diameter than those with Wolff-Parkinson-White syndrome (33 +/- 6, 39 +/- 10 and 46 +/- 5 versus 19.5 +/- 2 mm/m2, p less than 0.01, p less than 0.001 and p less than 0.001, respectively), also demonstrated a much smaller percent of alpha-myosin heavy chain content (28 +/- 20, 23.5 +/- 13 and 12 +/- 10 versus 58 +/- 18%, p less than 0.01, p less than 0.01 and p less than 0.001, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. Vanderheyden, W. Mullens, L. Delrue, M. Goethals, B. de Bruyne, W. Wijns, P. Geelen, S. Verstreken, F. Wellens, and J. Bartunek
Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Rucker-Martin, F. Pecker, D. Godreau, and S. N Hatem
Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro
Cardiovasc Res, July 1, 2002; 55(1): 38 - 52.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
B Swynghedauw and D Charlemagne
What is wrong with positive inotropic drugs? Lessons from basic science and clinical trials
Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D43 - D49.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
C. Aime-Sempe, T. Folliguet, C. Rucker-Martin, M. Krajewska, S. Krajewski, M. Heimburger, M. Aubier, J.-J. Mercadier, J. C. Reed, and S. N. Hatem
Myocardial cell death in fibrillating and dilated human right atria
J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1577 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C.P. Clifford and D.J.R. Nunez
Human {beta}-myosin heavy chain mRNA prevalence is inversely related to the degree of methylation of regulatory elements
Cardiovasc Res, June 1, 1998; 38(3): 736 - 743.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J.-J. Mercadier, K. Schwartz, S. Schiaffino, C. Wisnewsky, S. Ausoni, M. Heimburger, R. Marrash, R. Pariente, and M. Aubier
Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation
Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L527 - L534.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. L Young, A. L Gundlach, and W. J Louis
Altered cardiac hormone and contractile protein messenger RNA levels following left ventricular myocardial infarction in the rat: an in situ hybridization histochemical study
Cardiovasc Res, January 1, 1998; 37(1): 187 - 201.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Wiesner, H. Ehmke, J. Faulhaber, R. Zak, and J. C. Ruegg
Dissociation of Left Ventricular Hypertrophy, ß-Myosin Heavy Chain Gene Expression, and Myosin Isoform Switch in Rats After Ascending Aortic Stenosis
Circulation, March 4, 1997; 95(5): 1253 - 1259.
[Abstract] [Full Text]


Home page
CirculationHome page
G. de Simone, R. B. Devereux, M. J. Koren, G. A. Mensah, P. N. Casale, and J. H. Laragh
Midwall Left Ventricular Mechanics : An Independent Predictor of Cardiovascular Risk in Arterial Hypertension
Circulation, January 15, 1996; 93(2): 259 - 265.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1987 by the American College of Cardiology Foundation.